Skip to main content

Articles By John Swope

  • Playbook
    • By John Swope
    • 10 Nov 2019

    The annual ACR/ARP meeting will begin today, Sunday. For many this is the premier meeting in rheumatology. For the ACR it is their biggest educational event.

  • Hands with PSA
    • By John Swope
    • 22 Oct 2019
    I think 2018 was the year that belonged to psoriatic arthritis (although some may argue in favor of immune conditions induced by Checkpoint inhibitors). Many years ago the late Professor Verna Wright in Leeds (UK) was a lone voice for many years describing the clinical subtypes of Psoriatic arthritis as something distinctive from rheumatoid arthritis. For a long time we thought that the treatments for PsA were just the same as RA since we were treating the same problem of synovitis.
  • Rx Update
    • By John Swope
    • 10 Oct 2019

    Body text

  • Screengrab of the ACR coverage site
    • By John Swope
    • 09 Oct 2019

    Rheumatology has a comprehensive overview of methotrexate (MTX) and the risk of lung injury, MTX-related pneumonitis and interstitial lung disease (RA-ILD) with rheumatoid arthritis (RA).  Past reports suggest the frequence of MTX-pneumonitis to be between 0.3 and 11.6%; recent studies s

  • ACR Meeting Day 4
    • By John Swope
    • 02 Oct 2019
    Highlights from Tuesday, day 3 of the ACR Annual meeting in Chicago, included The PEXIVAS Study, ACR Reproductive Health Draft Guidelines, and Tofacitinib in refractory dermatomyositis
  • Meeting table with mics
    • By John Swope
    • 19 Sep 2019
    Highlights from Tuesday and Wednesday (days 3 and 4) from the ACR annual meeting include: the important and impactful abstracts covered by the Rheumatology Roundup session; upadacitinib clinical trials; and the baricitinib CV and VTE safety analysis.
  • Coupe
    • By John Swope
    • 19 Sep 2019

    Pregnancy for patients with lupus has long been considered high risk and associated with both medical and obstetric complications, but outcomes have improved over the last 2 decades and continue to improve.

  • Hip
    • By John Swope
    • 18 Sep 2019
    JAMA reports on a large Medicare cohort study showing that amongst patients undergoing total joint replacement (TJR), preoperative HbA1c testing was performed in 26% to 43% of patients with diabetes and in only 5% of those without diabetes. Importantly research has shown that an elevated HbA1c level is associated with postoperative complications.
    • By John Swope
    • 18 Sep 2019

    Pregnancy for patients with lupus has long been considered high risk and associated with both medical and obstetric complications, but outcomes have improved over the last 2 decades and continue to improve.

  • IL-2 inhibitor
    • By John Swope
    • 18 Sep 2019
    A double-blind, placebo-controlled clinical trial of low-dose IL-2 in patients with systemic lupus erythematosus (SLE) has shown that low-dose IL-2 induced was clinically effective while expandng regulatory T cells and NK cells, which may benefit immune homeostasis in SLE patients.
×